Search research articles
Contact Us
Filters
Showing results (401-410 of 977) with videos related to
Page
of 98
Sort By:
Oncology Research and Treatment
|
June 17, 2020
A Randomized Phase IIa Trial with Temsirolimus versus Sunitinib in Advanced Non-Clear Cell Renal Cell Carcinoma: An Intergroup Study of the CESAR Central European Society for Anticancer Drug Research-EWIV and the Interdisciplinary Working Group on Renal Cell Cancer (IAGN) of the German Cancer Society
Lothar Bergmann, Viktor Grünwald, Luise Maute, et al.
The American Journal of Pathology
|
February 12, 2014
Solitary fibrous tumors/hemangiopericytomas with different variants of the NAB2-STAT6 gene fusion are characterized by specific histomorphology and distinct clinicopathological features
Sarah Barthelmeß, Helene Geddert, Carsten Boltze, et al.
International Journal of Oncology
|
July 13, 2005
High-throughput tissue microarray analysis of COX2 expression in urinary bladder cancer
Peter J Wild, Leoni A Kunz-Schughart, Robert Stoehr, et al.
Clinical Oral Investigations
|
January 24, 2019
Predictive value of FHIT, p27, and pERK1/ERK2 in salivary gland carcinomas: a retrospective study
Mathias Fiedler, Patty Renner, Jürgen Schubert, et al.
The Journal of Pathology
|
May 11, 2013
Lack of evidence for frequent MED12 p.L1224F mutation in prostate tumours from Caucasian patients
Robert Stoehr, Helge Taubert, Nadine T Gaisa, et al.
The American Journal of Surgical Pathology
|
February 25, 2020
Report From the International Society of Urological Pathology (ISUP) Consultation Conference On Molecular Pathology Of Urogenital Cancers. II. Molecular Pathology of Bladder Cancer: Progress and Challenges
Joshua I Warrick, Margaret A Knowles, Allory Yves, et al.
Cancers
|
March 28, 2020
Pure Large Nested Variant of Urothelial Carcinoma (LNUC) Is the Prototype of an <i>FGFR3</i> Mutated Aggressive Urothelial Carcinoma with Luminal-Papillary Phenotype
Veronika Weyerer, Markus Eckstein, Eva Compérat, et al.
BMC Cancer
|
July 9, 2016
Technical validation of an RT-qPCR in vitro diagnostic test system for the determination of breast cancer molecular subtypes by quantification of ERBB2, ESR1, PGR and MKI67 mRNA levels from formalin-fixed paraffin-embedded breast tumor specimens
Mark Laible, Kornelia Schlombs, Katharina Kaiser, et al.
Oncotarget
|
May 13, 2017
FOXM1 predicts overall and disease specific survival in muscle-invasive urothelial carcinoma and presents a differential expression between bladder cancer subtypes
Sebastien Rinaldetti, Ralph Markus Wirtz, Thomas Stefan Worst, et al.
The American Journal of Surgical Pathology
|
May 29, 2023
International Society of Urological Pathology (ISUP) Consensus Conference on Current Issues in Bladder Cancer. Working Group 1: Comparison of Bladder Cancer Grading System Performance
Michelle R Downes, Arndt Hartmann, Steven Shen, et al.
Page
of 98
Search research articles
Search
Showing results (401-410 of 977) with videos related to
Sort By:
Page
of 98
Oncology Research and Treatment
|
June 17, 2020
A Randomized Phase IIa Trial with Temsirolimus versus Sunitinib in Advanced Non-Clear Cell Renal Cell Carcinoma: An Intergroup Study of the CESAR Central European Society for Anticancer Drug Research-EWIV and the Interdisciplinary Working Group on Renal Cell Cancer (IAGN) of the German Cancer Society
Lothar Bergmann, Viktor Grünwald, Luise Maute, et al.
The American Journal of Pathology
|
February 12, 2014
Solitary fibrous tumors/hemangiopericytomas with different variants of the NAB2-STAT6 gene fusion are characterized by specific histomorphology and distinct clinicopathological features
Sarah Barthelmeß, Helene Geddert, Carsten Boltze, et al.
International Journal of Oncology
|
July 13, 2005
High-throughput tissue microarray analysis of COX2 expression in urinary bladder cancer
Peter J Wild, Leoni A Kunz-Schughart, Robert Stoehr, et al.
Clinical Oral Investigations
|
January 24, 2019
Predictive value of FHIT, p27, and pERK1/ERK2 in salivary gland carcinomas: a retrospective study
Mathias Fiedler, Patty Renner, Jürgen Schubert, et al.
The Journal of Pathology
|
May 11, 2013
Lack of evidence for frequent MED12 p.L1224F mutation in prostate tumours from Caucasian patients
Robert Stoehr, Helge Taubert, Nadine T Gaisa, et al.
The American Journal of Surgical Pathology
|
February 25, 2020
Report From the International Society of Urological Pathology (ISUP) Consultation Conference On Molecular Pathology Of Urogenital Cancers. II. Molecular Pathology of Bladder Cancer: Progress and Challenges
Joshua I Warrick, Margaret A Knowles, Allory Yves, et al.
Cancers
|
March 28, 2020
Pure Large Nested Variant of Urothelial Carcinoma (LNUC) Is the Prototype of an <i>FGFR3</i> Mutated Aggressive Urothelial Carcinoma with Luminal-Papillary Phenotype
Veronika Weyerer, Markus Eckstein, Eva Compérat, et al.
BMC Cancer
|
July 9, 2016
Technical validation of an RT-qPCR in vitro diagnostic test system for the determination of breast cancer molecular subtypes by quantification of ERBB2, ESR1, PGR and MKI67 mRNA levels from formalin-fixed paraffin-embedded breast tumor specimens
Mark Laible, Kornelia Schlombs, Katharina Kaiser, et al.
Oncotarget
|
May 13, 2017
FOXM1 predicts overall and disease specific survival in muscle-invasive urothelial carcinoma and presents a differential expression between bladder cancer subtypes
Sebastien Rinaldetti, Ralph Markus Wirtz, Thomas Stefan Worst, et al.
The American Journal of Surgical Pathology
|
May 29, 2023
International Society of Urological Pathology (ISUP) Consensus Conference on Current Issues in Bladder Cancer. Working Group 1: Comparison of Bladder Cancer Grading System Performance
Michelle R Downes, Arndt Hartmann, Steven Shen, et al.
Page
of 98